PIK3CA MUTANT METASTATIC BREAST CANCER

Clinical trials for PIK3CA MUTANT METASTATIC BREAST CANCER explained in plain language.

Never miss a new study

Get alerted when new PIK3CA MUTANT METASTATIC BREAST CANCER trials appear

Sign up with your email to follow new studies for PIK3CA MUTANT METASTATIC BREAST CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Not yet finished but already full! 1

New drug combo tested for Tough-to-Treat breast cancer

Disease control Ongoing

This study is testing whether adding the drug alpelisib to standard hormone therapy can help control advanced breast cancer that has a specific genetic change (PIK3CA mutation) and has stopped responding to hormone therapy alone. It will involve about 44 adults with this type of …

Matched conditions: PIK3CA MUTANT METASTATIC BREAST CANCER

Phase: PHASE2 • Sponsor: Marina N Sharifi • Aim: Disease control

Last updated Mar 30, 2026 14:28 UTC

PIK3CA MUTANT METASTATIC BREAST CANCER

Get alerted when new PIK3CA MUTANT METASTATIC BREAST CANCER trials appear

New drug combo tested for Tough-to-Treat breast cancer